Pluripotent stem cells of the mouse as a potential in vitro model for mammalian germ cells. Sister chromatid exchanges induced by MMC and ENU in undifferentiated cell lines compared to differentiated cell lines

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 444, Issue 1, 1999, Pages 97-102

  Bremer, Susanne ^a   Vogel, Richard ^a  

^a Fed Inst Hlth Protect C   (Germany)

Author keywords

Embryonal carcinoma cell; Embryonal stem cell; Germ cell mutagen; Reproductive toxicity testing; Sister chromatid exchange

Indexed keywords

ETHYLNITROSOUREA; MITOMYCIN C;

ANIMAL CELL; ARTICLE; BACTERIUM CULTURE; BLASTOCYST; CARCINOMA CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; GENOTOXICITY; GERM CELL; IN VITRO STUDY; MALE; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; SISTER CHROMATID EXCHANGE; STEM CELL; TERATOCARCINOMA;

ANIMALS; CARCINOMA, EMBRYONAL; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; ETHYLNITROSOUREA; GERM CELLS; MICE; MITOMYCIN; MODELS, BIOLOGICAL; MUTAGENICITY TESTS; MUTAGENS; SISTER CHROMATID EXCHANGE; STEM CELLS; TUMOR CELLS, CULTURED;

MAMMALIA; MURINAE;

EID: 0032804827     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(99)00090-X     Document Type: Article

References (33)

1. European Commission, Technical Guidance Document in support of the Commission Directive 93/67/EEC on risk assessment for new notified substances and the Commission Regulation (EC) 1488/94 on risk assessment for existing substances, Part I, Chap. 2, paragraph 3.12.8.2, 1996.
2. ECVAM Workshop Report 12, Screening chemicals for reproductive toxicity: the current alternatives, ATLA, Vol. 23, 1995, pp. 868-882.
3. Vogel R. In vitro aproach to fertility research: genotoxicity tests on primordial germ cells and embryonic stem cells. Reprod. Toxicol. 7:1993;69-73.
4. Matsui Y., Zsebok K., Hogan B. Derivation of pluripotenial embryonic stem cells from murine primordial germ cells in culture. Cell. 70:1992;841-847.
5. Evans M.J., Kaufman M.H. Establishment in culture of pluripotent cells from mouse embryo. Nature. 292:1981;154-156.
6. Doetschmann T.C., Eistetter H., Katz M., Schmidt W., Kemler R. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87:1985;27-45.
7. Hass P.E., Wada H.G., Herman M.M., Sussman H.H. Alkaline phosphatase of mouse teratoma stem cells: immunochemical and structural evidence for its identity as a somatic gene product. Proc. Natl. Acad. Sci. 76:1979;1164-1168.
8. Solter D., Knowles B. Monoclonal antibody defining a stage-specific mouse embryonic antigene (SSEA-1). Proc. Natl. Acad. Sci. 75:1978;5565-5569.
9. Chiquoine A.D. The identification, origin and migration of the primordial germ cells in the mouse embryo. Anat. Res. 118:1954;135-136.
10. Gossler A., Doetschman T., Korn R., Serfling E., Kemler R. Transgenesis by means of blastocyst derived embryonic stem cell lines. Proc. Natl. Acad. Sci. 83:1986;9065-9069.
11. Kühn M.R., Bradley A., Robertson E.J., Evans M.J. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations in mice. Nature. 326:1987;295-298.
12. Reznikoff C.A., Brankow D.W., Heidelberger C. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res. 33:1973;3231-3238.
13. McBurney M.W., Jones-Villeneuve E.M., Edwards M.K.S., Anderson P.J. Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line. Nature. 299:1982;165-167.
14. Mummery C.L., van Rooijen M.A., van den Brink C.E., de Laat S.W. Cell Cycle analysis during retinoic acid induced differentiation of human carcinoma derived cell line. Cell. Differ. 20:1987;153-160.
15. Smith A.G., Hooper M.L. Buffalo rat liver cell produces a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev. Biol. 121:1987;1-9.
16. Tice R., Schneider E.L., Rary J.M. The utilization of bromodeoxyyuridine incorporation into DNA for the analysis of cellular kinetics. Exp. Cell Res. 102:1976;232-236.
17. Perry P., Wolff S. New Giemsa method for the differential staining of sister chromatids. Nature. 251:1974;156-158.
18. Vogel R., Laschinski G., Spielmann H. High frequency of sister chromatid exchanges in pluripotent cells derived from early mouse embryos. J. Occup. Med. Toxicol. 1:1992;301-306.
19. Vogel R., Spielmann H. Cytotoxic and genotoxic effects of bromodeoxyuridine during in vitro labelling for sister chromatid differentiation in preimplantation mouse embryos. Mutat. Res. 209:1988;75-78.
20. Vogel R., Granata I., Spielmann H. Cytogentic studies on preimplantation mouse embryos exposed to methylnitrosourea in vivo. Reprod. Toxicol. 3:1989;23-26.
21. Sehlmeyer U., Wobus A.M. Lower mutation frequencies are induced by ENU in undifferentiated embryonic cells than in differentiated cells of the mouse in vitro. Mutat. Res. 324:1994;69-74.
22. Sehlmeyer U., Wobus A.M. MNNG is less cytotoxic and mutagenic in undifferentiated embryonic cells than in differentiated cells of the mouse in vitro. In Vitro Toxicol. 8:1995;121-127.
23. Fabricant J.D., Hofnung M.J., Kelly F. Sister-chromatid exchange induction by mitomycin C is deficient in embryonal carcinoma cells. Mutat. Res. 63:1979;215-219.
24. Cole S.P., Bhardway G., Gerlach J.H. Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line. Science. 228:1992;1650-1654.
25. Lizard G., Chignol M.C., Chardonnet Y. Active cell membrane mechanisms involved in the exclusion of RH 123 allow distinction between normal and tumoral cells. Cell Biol. Toxicol. 10:1994;399-409.
26. Chao C.C. Constitutive over expression of DNA damage recognition proteins and acquired UV resistence in prolonged culture of F9 teratocarcinoma stem cells. FEBS letters. 329:1993;253-258.
27. Rasko I., Georgeva M., Farkas G., Santha M., Coates J., Burg K., Mitchell D.L., Johnson R.T. New patters of bulk DNA repair in ultraviolet irradiated mouse embryo carcinoma cells following differentation. Somatic Cell. Mol. Genet. 19:1993;245-255.
28. Shellard S.A., Fichtinger-Shepman A.M., Laze J.S., Hill B.T. Evidence of a differential cisplatin-DNA adduct formation, removal and tolerance of DNA damage in three human lung carcinoma lines. Anti-Cancer Drugs. 4:1993;491-500.
29. Epstein R.J. Drug reduced DNA damage and tumor chemosensitivity. J. Clin. Oncol. 8:1990;2062-2084.
30. Dolci S., Williams D.E., Ernst M.K., Resnik J.C., Brannan C.I., Loch F.F., Lyman S.D., Boswell H.S., Donovan P.I. Requirement for mast cell growth factor for primordial germ cell survival in culture. Nature. 352:1991;808-811.
31. Godin J., Deed R., Cooke J., Zsebo K., Dexter M., Wylie C.C. Effects of the steel gene product on mouse primordial germ cells in culture. Nature. 353:1991;807-809.
32. Matsui Y., Totsoz D., Nishikawa S., Nishikawa S.I., Williams D., Zsebo K., Hogan B. Effect of steel factor and leukemia inhibitory factor on murine primordial germ cells in culture. Nature. 353:1991;750-751.
33. Resnick J.L., Bixler L.S., Cheng L., Donovan P.J. Long term proliferation of mouse primordial germ cells in culture. Nature. 359:1992;550-551.